サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1750791

動物用CRO・CDMOの市場規模、シェア、動向分析レポート：動物別、サービス別、用途別、地域別、セグメント予測、2025年～2030年

Veterinary CRO And CDMO Market Size, Share & Trends Analysis Report By Animal (Companion Animals, Livestock Animals), By Service (Discovery, Development), By Application (Medicine, Medical Devices), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.63円
動物用CRO・CDMOの市場規模、シェア、動向分析レポート：動物別、サービス別、用途別、地域別、セグメント予測、2025年～2030年
出版日: 2025年05月07日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

動物用CRO・CDMO市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の動物用CRO・CDMOの市場規模は2030年までに114億2,000万米ドルに達し、2025年から2030年にかけてCAGR9.2％で拡大すると予測されています。

動物ヘルスケアへの支出の増加、研究開発などのプロセスのアウトソーシング志向の高まり、効果的な動物用医薬品ソリューションに対する世界の需要の高まりが、市場成長の原動力になると見られています。

畜産動物の生命を脅かす病気を予防するための安全で効率的なワクチン開発への多額の投資、コンパニオンアニマル用に設計された新規医薬品の需要の伸び、ペット飼育の増加がこの市場に影響を与えています。さらに、CROが提供する技術力、CDMOの高度な設備能力、改善されたサプライチェーン管理、容易な流通が成長に寄与しています。

臨床試験、研究、発見、開発など様々な用途で、動物用医薬品メーカーとCROやCDMOとの協力関係の高まりは、有利な機会を生み出す可能性が高いです。主要市場参入企業によるポートフォリオ強化、生産能力拡大、プロセス改善への注目すべき投資は、予測期間中の成長を促進すると予測されます。

動物用CRO・CDMO市場レポートハイライト

  • 畜産動物セグメントは、畜産動物に関連する食肉やその他の製品別の安全性に関する懸念の高まり、新型疾病の頻繁な発生、効果的なワクチンに対する需要の高まりにより、2024年の収益シェアで55%以上を占め、世界市場を独占しました。
  • コンパニオンアニマルセグメントは、ペット用に特別に設計された医薬品や機器など、様々な動物用健康製品の採用が大幅に増加しているため、急成長が見込まれています。
  • 開発セグメントは、動物の健康と栄養に関連する革新的な製品の開発に複数の動物用医薬品企業が注力するようになったため、2024年の市場で最大の収益シェアを占めました。
  • 2025年から2030年にかけては、動物用医薬品に関する研究活動への投資が増加していることから、探索分野が最も急成長すると予想されています。
  • 用途別では、医薬品分野が2024年に最も高い市場収益シェアを占めました。
  • 北米は、製薬・バイオテクノロジー産業が強く、複数のCRO・CDMOが存在し、動物用医薬品への支出が増加していることから、2024年の世界産業を支配しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 世界の動物用CRO・CDMO市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/補助市場展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 世界の動物用CRO・CDMO市場分析ツール
    • 業界分析-ポーターのファイブフォース分析
    • PESTLE分析

第4章 世界の動物用CRO・CDMO市場：動物ビジネス分析

  • 動物セグメントダッシュボード
  • 動物用CRO・CDMO市場：動物の変動分析
  • 世界の動物用CRO・CDMO市場規模と動向分析（動物別、2018～2030年）
  • コンパニオンアニマル
  • 家畜

第5章 世界の動物用CRO・CDMO市場：サービスビジネス分析

  • サービスセグメントダッシュボード
  • 動物用CRO・CDMO市場：サービス変動分析
  • 世界の動物用CRO・CDMO市場規模と動向分析（サービス別、2018～2030年）
  • 発見
  • 開発
  • 製造業
  • 包装とラベル
  • 市場承認と市販後調査

第6章 世界の動物用CRO・CDMO市場：用途ビジネス分析

  • 用途セグメントダッシュボード
  • 動物用CRO・CDMO市場：用途変動分析
  • 世界の動物用CRO・CDMO市場規模と動向分析（用途別、2018～2030年）
  • 医薬品
  • 医療機器

第7章 世界の動物用CRO・CDMO市場：地域推定・動向分析

  • 地域市場ダッシュボード
  • 地域別市場シェア分析、2024年・2030年
  • 地域別世界動物用CRO・CDMO市場：主なポイント
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • コロンビア
    • アルゼンチン
    • チリ
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 最近の動向と影響分析：主要市場参入企業別
  • 企業/競合の分類
  • ベンダー情勢
    • 主要企業のヒートマップ分析、2024年
  • 企業プロファイル
    • Fortrea
    • Charles River Laboratories
    • Clinvet（Clinglobal）
    • KLIFOVET GmbH（Argenta Group）
    • OCRvet（Clinglobal）
    • Knoell-Triveritas
    • Veterinary Research Management
    • VETSPIN SRL
    • Inotiv
    • IDEXX
    • Vetio
    • TriRx Pharmaceutical Services
図表

List of Tables

  • Table 1. List Of Abbreviations
  • Table 2. Global Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 3. Global Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 4. Global Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 5. Global Veterinary CRO and CDMO Market, By Region, 2018 - 2030 (USD Million)
  • Table 6. North America Veterinary CRO and CDMO Market, By Country, 2018 - 2030 (USD Million)
  • Table 7. North America Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 8. North America Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 9. North America Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 10. U.S. Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 11. U.S Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 12. U.S. Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 13. Canada Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 14. Canada Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 15. Canada Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 16. Mexico Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 17. Mexico Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 18. Mexico Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 19. Europe Veterinary CRO and CDMO Market, By Country, 2018 - 2030 (USD Million)
  • Table 20. Europe Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 21. Europe Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 22. Europe Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 23. Germany Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 24. Germany Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 25. Germany Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 26. UK Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 27. UK Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 28. UK Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 29. France Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 30. France Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 31. France Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 32. Italy Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 33. Italy Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 34. Italy Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 35. Spain Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 36. Spain Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 37. Spain Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 38. Denmark Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 39. Denmark Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 40. Denmark Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 41. Sweden Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 42. Sweden Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 43. Sweden Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 44. Norway Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 45. Norway Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 46. Norway Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 47. Asia Pacific Veterinary CRO and CDMO Market, By Country, 2018 - 2030 (USD Million)
  • Table 48. Asia Pacific Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 49. Asia Pacific Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 50. Asia Pacific Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 51. China Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 52. China Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 53. China Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 54. Japan Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 55. Japan Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 56. Japan Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 57. India Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 58. India Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 59. India Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 60. Australia Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 61. Australia Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 62. Australia Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 63. South Korea Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 64. South Korea Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 65. South Korea Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 66. Thailand Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 67. Thailand Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 68. Thailand Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 69. Latin America Veterinary CRO and CDMO Market, By Country, 2018 - 2030 (USD Million)
  • Table 70. Latin America Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 71. Latin America Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 72. Latin America Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 73. Brazil Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 74. Brazil Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 75. Brazil Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 76. Columbia Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 77. Columbia Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 78. Columbia Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 79. Argentina Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 80. Argentina Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 81. Argentina Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 82. Chile Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 83. Chile Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 84. Chile Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 85. MEA Veterinary CRO and CDMO Market, By Region, 2018 - 2030 (USD Million)
  • Table 86. MEA Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 87. MEA Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 88. MEA Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 89. South Africa Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 90. South Africa Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 91. South Africa Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 92. Saudi Arabia Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 93. Saudi Arabia Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 94. Saudi Arabia Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 95. UAE Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 96. UAE Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 97. UAE Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)
  • Table 98. Kuwait Veterinary CRO and CDMO Market, By Animal, 2018 - 2030 (USD Million)
  • Table 99. Kuwait Veterinary CRO and CDMO Market, By Service, 2018 - 2030 (USD Million)
  • Table 100 Kuwait Veterinary CRO and CDMO Market, By Application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Veterinary CRO and CDMO Market: Market Outlook
  • Fig. 10 Veterinary CRO and CDMO Competitive Insights
  • Fig. 11 Parent Market Outlook
  • Fig. 12 Related/Ancillary Market Outlook
  • Fig. 13 Penetration and Growth Prospect Mapping
  • Fig. 14 Industry Value Chain Analysis
  • Fig. 15 Veterinary CRO and CDMO Market Driver Impact
  • Fig. 16 Veterinary CRO and CDMO Market Restraint Impact
  • Fig. 17 Veterinary CRO and CDMO Market Strategic Initiatives Analysis
  • Fig. 18 Veterinary CRO and CDMO Market: Animal Movement Analysis
  • Fig. 19 Veterinary CRO and CDMO Market: Animal Outlook and Key Takeaways
  • Fig. 20 Companion Animal Market Estimates and Forecast, 2018 - 2030
  • Fig. 21 Livestock Animal Market Estimates and Forecast, 2018 - 2030
  • Fig. 22 Veterinary CRO and CDMO Market: Service Movement Analysis
  • Fig. 23 Veterinary CRO and CDMO Market: Service Outlook and Key Takeaway
  • Fig. 24 Discovery Market Estimates and Forecast, 2018 - 2030
  • Fig. 25 Development Market Estimates and Forecast, 2018 - 2030
  • Fig. 26 Early Phase/Preclinical Development Market Estimates and Forecast, 2018 - 2030
  • Fig. 27 Late phase/Clinical Development Market Estimates and Forecast, 2018 - 2030
  • Fig. 28 Manufacturing Market Estimates and Forecast, 2018 - 2030
  • Fig. 29 Packaging & Labeling Market Estimates and Forecast, 2018 - 2030
  • Fig. 30 Market Approval & Post Marketing Market Estimates and Forecast, 2018 - 2030
  • Fig. 31 Veterinary CRO and CDMO Market: Application Movement Analysis
  • Fig. 32 Veterinary CRO and CDMO Market: Application Outlook and Key Takeaways
  • Fig. 33 Medicine Market Estimates and Forecast, 2018 - 2030
  • Fig. 34 Pharmaceuticals Market Estimates and Forecast, 2018 - 2030
  • Fig. 35 Biologics Market Estimates and Forecast, 2018 - 2030
  • Fig. 36 Others Market Estimates and Forecast, 2018 - 2030
  • Fig. 37 Medical Devices Market Estimates and Forecast, 2018 - 2030
  • Fig. 38 Global Veterinary CRO and CDMO Market: Regional Movement Analysis
  • Fig. 39 Global Veterinary CRO and CDMO Market: Regional Outlook and Key Takeaways
  • Fig. 40 North America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 41 U.S. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 42 Canada Market Estimates and Forecasts, 2018 - 2030
  • Fig. 43 Mexico Market Estimates and Forecasts, 2018 - 2030
  • Fig. 44 Europe Market Estimates and Forecasts, 2018 - 2030
  • Fig. 45 UK Market Estimates and Forecasts, 2018 - 2030
  • Fig. 46 Germany Market Estimates and Forecasts, 2018 - 2030
  • Fig. 47 France Market Estimates and Forecasts, 2018 - 2030
  • Fig. 48 Italy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 49 Spain Market Estimates and Forecasts, 2018 - 2030
  • Fig. 50 Denmark Market Estimates and Forecasts, 2018-203
  • Fig. 51 Sweden Market Estimates and Forecasts, 2018-203
  • Fig. 52 Norway Market Estimates and Forecasts, 2018-203
  • Fig. 53 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
  • Fig. 54 China Market Estimates and Forecasts, 2018 - 2030
  • Fig. 55 Japan Market Estimates and Forecasts, 2018 - 2030
  • Fig. 56 India Market Estimates and Forecasts, 2018 - 2030
  • Fig. 57 Australia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 58 South Korea Market Estimates and Forecasts, 2018 - 2030
  • Fig. 59 Thailand Market Estimates and Forecasts, 2018 - 2030
  • Fig. 60 Latin America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 61 Brazil Market Estimates and Forecasts, 2018 - 2030
  • Fig. 62 Columbia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 63 Argentina Market Estimates and Forecasts, 2018 - 2030
  • Fig. 64 Chile Market Estimates and Forecasts, 2018 - 2030
  • Fig. 65 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 66 South Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 67 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 68 UAE Market Estimates and Forecasts, 2018 - 2030
  • Fig. 69 Kuwait Market Estimates and Forecasts, 2018 - 2030
目次
Product Code: GVR-4-68040-053-0

Veterinary CRO And CDMO Market Growth & Trends:

The global veterinary CRO and CDMO market size is anticipated to reach USD 11.42 billion by 2030 and is anticipated to expand at a CAGR of 9.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing expenditure on animal healthcare, growing inclination toward outsourcing processes such as research and development, and rising demand for effective animal health solutions worldwide are expected to drive market growth.

Significant investments in developing safe and efficient vaccines to prevent life-threatening diseases in livestock animals, growth in demand for novel medicines designed for companion animals, and an increase in pet ownership influence this market. In addition, the technical competence offered by CROs, advanced equipment capabilities of CDMOs, improved supply chain management, and easy distribution contribute to growth.

Rising collaborations among animal health companies and CROs or CDMOs for various applications, including clinical trials, research, discovery, and development, are likely to develop lucrative opportunities. Noteworthy investments by key market participants in portfolio enhancement, capacity expansion, and improved processes are projected to aid growth over the forecast period.

Veterinary CRO And CDMO Market Report Highlights:

  • Livestock animals segment dominated the global market with more than 55% of revenue share in 2024 owing to growing concerns regarding the safety of meat and other byproducts associated with livestock animals, frequent outbreaks of novel diseases, and increasing demand for effective vaccines
  • The companion animals segment is expected to experience the fastest growth due to the significant increase in the adoption of various animal health products, such as medicine and devices specifically designed for pets
  • The development segment held the largest revenue share of the market in 2024, owing to the rising focus of multiple animal health companies on developing innovative products related to animal health and nutrition.
  • The discovery segment is expected to experience the fastest growth from 2025 to 2030, owing to increasing investment in research activities related to animal health products
  • In terms of application segment, medicine segment accounted for the highest market revenue share in 2024
  • North America dominated the global industry in 2024, owing to its strong pharmaceutical and biotechnology industry, presence of multiple CROs and CDMOs, and growing expenditures on animal health

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Animal
    • 1.2.2. Service
    • 1.2.3. Application
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Animal Outlook
    • 2.2.2. Service Outlook
    • 2.2.3. Application Outlook
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Veterinary CRO and CDMO Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Global Veterinary CRO and CDMO Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Global Veterinary CRO and CDMO Market: Animal Business Analysis

  • 4.1. Animal Segment Dashboard
  • 4.2. Veterinary CRO and CDMO Market: Animal Movement Analysis
  • 4.3. Global Veterinary CRO and CDMO Market Size & Trend Analysis, By Animal, 2018 to 2030 (USD Million)
  • 4.4. Companion Animals
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5. Livestock Animals
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Global Veterinary CRO and CDMO Market: Service Business Analysis

  • 5.1. Service Segment Dashboard
  • 5.2. Veterinary CRO and CDMO Market: Service Movement Analysis
  • 5.3. Global Veterinary CRO and CDMO Market Size & Trend Analysis, By Service, 2018 to 2030 (USD Million)
  • 5.4. Discovery
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Development
    • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.2. Early Phase/Preclinical
      • 5.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.3. Late phase/Clinical
      • 5.5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6. Manufacturing
    • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7. Packaging & Labeling
    • 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.8. Market Approval & Post Marketing
    • 5.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Global Veterinary CRO and CDMO Market: Application Business Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. Veterinary CRO and CDMO Market: Application Movement Analysis
  • 6.3. Global Veterinary CRO and CDMO Market Size & Trend Analysis, By Application, 2018 to 2030 (USD Million)
  • 6.4. Medicine
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Pharmaceuticals
      • 6.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Biologics
      • 6.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Others
      • 6.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5. Medical Devices
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Global Veterinary CRO and CDMO Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2024 & 2030
  • 7.3. Global Veterinary CRO and CDMO Market by Regional: Key Takeaways
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key Country Dynamics
      • 7.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.1.3. Competitive Scenario
      • 7.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Germany
      • 7.5.1.1. Key Country Dynamics
      • 7.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.1.3. Competitive Scenario
      • 7.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Italy
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.6.3. Competitive Scenario
      • 7.5.6.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.7.3. Competitive Scenario
      • 7.5.7.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.8.3. Competitive Scenario
      • 7.5.8.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.9.3. Competitive Scenario
      • 7.5.9.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key Country Dynamics
      • 7.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.1.3. Competitive Scenario
      • 7.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key Country Dynamics
      • 7.7.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.1.3. Competitive Scenario
      • 7.7.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Colombia
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. Colombia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Chile
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.4.3. Competitive Scenario
      • 7.7.4.4. Chile Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. South Africa
      • 7.8.1.1. Key Country Dynamics
      • 7.8.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.1.3. Competitive Scenario
      • 7.8.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. South Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.3.3. Competitive Scenario
      • 7.8.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.4.3. Competitive Scenario
      • 7.8.4.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key Company Heat Map Analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. Fortrea
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Charles River Laboratories
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Clinvet (Clinglobal)
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. KLIFOVET GmbH (Argenta Group)
      • 8.4.4.1. Company Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. OCRvet (Clinglobal)
      • 8.4.5.1. Company Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Knoell - Triveritas
      • 8.4.6.1. Company Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Veterinary Research Management
      • 8.4.7.1. Company Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. VETSPIN SRL
      • 8.4.8.1. Company Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Inotiv
      • 8.4.9.1. Company Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. IDEXX
      • 8.4.10.1. Company Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives
    • 8.4.11. Vetio
      • 8.4.11.1. Company Overview
      • 8.4.11.2. Financial Performance
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Strategic Initiatives
    • 8.4.12. TriRx Pharmaceutical Services
      • 8.4.12.1. Company Overview
      • 8.4.12.2. Financial Performance
      • 8.4.12.3. Product Benchmarking
      • 8.4.12.4. Strategic Initiatives